Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Novartis”
Sponsor: Dana-Farber Cancer Institute
Thyroid Cancer
United States
Sponsor: Novartis Pharmaceuticals
IGA Nephropathy
United States
Sponsor: Tourmaline Bio, Inc., a Novartis Company
Chronic Kidney Diseases · Chronic Kidney Insufficiency · Chronic Renal Diseases · Chronic Renal Insufficiency
United States
- Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic LeukemiaEnrolling By Invitation
Sponsor: SWOG Cancer Research Network
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia · CD19+ Acute Leukemia
United States
Sponsor: Washington University School of Medicine
Multiple Sclerosis (MS) - Relapsing-remitting
United States
- Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI PatientsRecruiting
Sponsor: Novartis Pharmaceuticals
Myocardial Infarction
Russia
Sponsor: Novartis Pharmaceuticals
Aplastic Anemia
United States, Hong Kong, Portugal, Russia, Thailand +1 more
Sponsor: Novartis Pharmaceuticals
Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease
United States, Puerto Rico
Sponsor: Novartis Pharmaceuticals
Immunoglobulin A Nephropathy (IgAN)
United States, Brazil, China, Czechia, Germany +6 more
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of OfatumumabActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis (RMS)
United States, Puerto Rico
Sponsor: Novartis Pharmaceuticals
Breast Cancer
Russia
- Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple SclerosisActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
United States, Australia, Austria, Brazil, Bulgaria +20 more
- A Study of Asciminib Safety and Efficacy in Young Adults With Chronic Myeloid Leukemia in the Gulf RegionNot Yet Recruiting
Sponsor: Novartis Pharmaceuticals
Chronic Myeloid Leukemia
Sponsor: Novartis Pharmaceuticals
Chronic Spontaneous Urticaria
Germany
Sponsor: Novartis Pharmaceuticals
Juvenile Idiopathic Arthritis
- Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal HemoglobinuriaActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Paroxysmal Nocturnal Hemoglobinuria
United States, Brazil, China, Czechia, France +12 more
Sponsor: Novartis Pharmaceuticals
Atypical Hemolytic Uremic Syndrome
United States, Brazil, China, Czechia, India +3 more
- A Study of DII235 in Adults With Elevated Lipoprotein(a)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Lipoprotein Disorder
United States, China, Germany, Japan
- PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADTNot Yet Recruiting
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
High-Risk Localized Prostate Cancer
United States
Sponsor: Novartis Pharmaceuticals
Paroxysmal Nocturnal Hemoglobinuria (PNH)
United States, Brazil, Colombia, Germany, Italy +1 more
Sponsor: Novartis Pharmaceuticals
C3 Glomerulopathy · Immune-complex-membranoproliferative Glomerulonephritis
United States, Argentina, Brazil, Canada, China +12 more
Sponsor: Novartis Pharmaceuticals
Berger Disease · Bergers Disease · IgA Nephropathy · Immunoglobulin A Nephropathy
United States, China, Japan, South Korea
- Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE StudyActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Atherosclerotic Vascular Disease · Heterozygous Familial Hypercholesterolemia
Spain
Sponsor: Novartis Pharmaceuticals
Atherosclerotic Cardiovascular Disease (ASCVD)
United States, China, France, Germany, Hong Kong +6 more
- Specified Drug-use Survey of Leqvio for s.c. Injection.Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Familial Hypercholesterolaemia · Hypercholesterolaemia
Japan